SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits

By sjmartinez • October 11, 2022

Dixit NM, Ziaeian B, Fonarow GC. SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits. Heart Fail Clin. 2022 Oct;18(4):587-596. doi: 10.1016/j.hfc.2022.03.003. PMID: 36216488.

Tags: Cardiology/Epi, Guideline-directed medical therapy, Heart failure with preserved ejection fraction, Heart failure with reduced ejection fraction, Initiation and sequencing, Publications

Barriers and Emerging Strategies to Bridge Gaps in Implementation of Evidence-Based Lipid-Lowering Therapies

Marnell CS, Koenig W, Bittner V, Watson KE, Muntner P, Nordestgaard BG, Yan LL, Verbakel M, Rosenson RS. Barriers and Emerging Strategies to Bridge Gaps[...]

New 10-Year Atherosclerosis Cardiovascular Disease Risk Score for Asian and American Indian Women Service Members

Jeon-Slaughter H, Whyne EZ, Doyle C, Chen X, Chiou SH, Tsai S, Ebrahimi R. New 10-Year Atherosclerosis Cardiovascular Disease Risk Score for Asian and American[...]

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]